This opportunity has been awarded. Its page stays for reference.
Similar open opportunities
- Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cinacalcet (ausschl. in der Normgröße N3), ATC H05BX01 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)
- Arzneimittelverträge mit Beitrittsoption
- Open-House-Originale-Rabattverträge 2026-13 Etrasimod
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan
At a glance
IKK classic is procuring Pharmaceutical products (CPV 33600000). It has been awarded. The notice states an estimated value of €1 excl. VAT. Procedure type: Negotiated without prior call for competition.
From the notice
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan (Wirkstoff: Morphin-hydrochlorid, ATC-Code WHO: N02AA01, ADV: N07BC09), Vertragslaufzeit: 01.10.2026-30.09.2028
Key facts
Each fact is from the official notice, last checked 7 November 2026, 13:30 (UTC+01:00).
- Status
- AwardedOfficial notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- Deadline
- No deadline in the noticeOfficial notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- Published value
- €1 excl. VATOfficial notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- Buyer
- IKK classic, Dresden, DEOfficial notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- Main CPV
- Pharmaceutical products (CPV 33600000)Official notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- Procedure
- Negotiated without prior call for competitionOfficial notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- Lots
- 1Official notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
- First published
- 16 September 2026, 14:49 (UTC+02:00)Official notice · checked 7 Nov 2026, 13:30 (UTC+01:00)
Fact sheet

Lots (1)
Lot LOT-0000: Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan (Wirkstoff: Morphin-hydrochlorid, ATC-Code WHO: N02AA01, ADV: N07BC09), Vertragslaufzeit: 01.10.2026-30.09.2028
Timeline
- Award: Award. Winner: G.L. Pharma Deutschland GmbH; Award value: €1 excl. VAT; Tenders received: 1; Lot LOT-0000.
- 16 September 2026, 14:49 (UTC+02:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice
Buyer and place
Buyer
IKK classic
Dresden, DE
Other parties in the notice
- G.L. Pharma Deutschland GmbH (Tenderer), Hamburg
- G.L. Pharma Deutschland GmbH (Winner), Hamburg
Classification
CPV codes
- 33600000: Pharmaceutical products
Official documents
No documents found in the indexed notice.
Questions and answers
Who is the buyer?
IKK classic, Dresden, DE.
What is being procured (CPV)?
Pharmaceutical products (CPV 33600000).
What is the estimated value?
The notice states an estimated value of €1 excl. VAT.
Is it divided into lots?
No, the notice names a single lot.
Which procedure is used?
Negotiated without prior call for competition.
How do I submit a bid?
On the official notice or the portal it names. Inteliwert does not submit bids. Official notice
Am I eligible?
Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice
More from this buyer
Other published opportunities of this buyer in the indexed notices, open ones first.
-
OpenTender
Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Last checked 7 Nov 2026, 14:30 (UTC+01:00)Official notice -
AwardedTender
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Besins Healthcare Germany GmbH zu Testogel
Last checked 6 Nov 2026, 07:11 (UTC+01:00)Official notice -
AwardedTender
Abschluss eines nicht-exklusiven Rabattvertrages gemäß§ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
Last checked 4 Nov 2026, 12:10 (UTC+01:00)Official notice
Source
- Publisher
- Bekanntmachungsservice
- Licence
- CC0 1.0
- Last checked
- 7 November 2026, 13:30 (UTC+01:00)
The official notice is authoritative. Inteliwert shows what the notice states and links to it.